Asthma treatment

http://www.healasthma.com – . (USA) – Determination That Protamine Sulfate Injection and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness, ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) has determined that the drug products listed in this document were not withdrawn from sale for reasons of safety or effectiveness.This determination means that FDA will not begin procedures to withdraw approval of abbreviated new drug applications (ANDAs) for the drug products, and it will allow FDA to continue to approve ANDAs for the products. FOR FURTHER INFORMATION CONTACT: Mary Catchings, Center for Drug Evaluation and… . (USA) – Semis Bounce from -Day Slide to Boost the Nasdaq [delayed] The Dow (unch) and S&P (+ . %) are little changed after an hour of trading but the Nasdaq is up . %. The semis (SOX + . %) are attempting to end a -day losing streak. Pacific Crest says rumors of an Intel capex cutback are overblown. Companies in the semi equipment and communications (analog) space are outperformers. Packaging and test firms AMKR and BRKS are up more than %. Broadcom (BRCM) is benefiting from a Barron’s story suggesting it and Freescale win Nokia… . (USA) – Small Caps & Nasdaq Names Outpace Blue Chips on Monday [delayed] The Dow (- ) underperformed the broad market on a day when investors sought out the higher beta, higher risk small caps. The Russell (RUT + . %) and S&P Midcaps (MDY + . %) handily outperformed the S&P (+ . %). The Nasdaq (+ . %) also helped to whet investors’ risk appetites. The bellwether semiconductor sector (SOX – . %) was once again passed by. The SOX gave up a . % midday gain and closed lower for the sixth consecutive session. With oil up… Critical Therapeutics’ Sales Force Gains Access to a Second Product as FDA Approves Co-Promotion Partner’s New Treatment for COPD FDA Approves DEY’s New Drug Application for Perforomist(TM) Inhalation Solution Critical Therapeutics Contact: Linda S. Lennox, – - Vice President, Investor & Media Relations llennox@crtx.com Critical Therapeutics, Inc. (Nasdaq: CRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved Dey, L.P.’s (DEY) New Drug Application for Perforomist(TM) (formoterol fumarate) Inhalation Solution for long-term, twice-daily… . M Presswire – AheadoftheBulls.com: Future Bulls HYBT, CRTX, UTVG New York-AheadoftheBulls.com, announces the following companies as high potential, Future Bulls: Hybrid Technologies, Inc. (OTC BB: HYBT), Critical Therapeutics Inc. (OTC BB: CRTX) and Universal Travel Group (OTC BB: UTVG) Come visit AheadoftheBulls.com to sign up for our free Newsletter, where you will receive detailed information on these companies and more! Hybrid Technologies, Inc. (OTC BB: HYBT, http://finance.yahoo.com/q?s=HYBT.OB) Hybrid… . wire (USA) – FDA Approves Dey, L.P.’s Perforomist(TM) (Formoterol Fumarate) Inhalation Solution for Maintenance Treatment of COPD, First nebulized formoterol fumarate offers patients twice-daily dosing for rapid, long-lasting relief of emphysema and chronic bronchitis — PRNewswire — Dey, L.P. announced today that the Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Perforomist(TM) (formoterol fumarate) Inhalation Solution for long-term, twice-daily maintenance treatment of bronchoconstriction for emphysema and chronic bronchitis, also known as Chronic Obstructive Pulmonary Disease (COPD). Formoterol is a rapid and long-lasting beta( ) agonist that has been previously approved in the U.S. as a dry powder formulation,… . EDGAR Online -K, -Q Glimpse Feed (USA) – -Q: LINCARE HOLDINGS INC Item . Management’s Discussion and Analysis of Results of Operations and Financial Condition Medicare Reimbursement As a supplier of home oxygen and other respiratory therapy services to the home health care market, we participate in Medicare Part B, the Supplementary Medical Insurance Program, which was established by the Social Security Act of . Providers of home oxygen and other respiratory therapy services have historically been heavily dependent on Medicare… . FD (FAIR DISCLOSURE) WIRE – Q CVS /Caremark Corporation Earnings Conference Call – Final OPERATOR: Good morning. My name is Cynthia and I will be your conference operator today. At this time, I would like to welcome everyone to the CVS/Caremark Corporation’s first quarter earnings conference call.All lines have been placed on mute to prevent any background noise. After the speaker’s remarks, there will be a question-and-answer session. (OPERATOR INSTRUCTIONS) I would now like to turn today’s call over to Nancy Christal, VP… . FD (FAIR DISCLOSURE) WIRE – Q CVS /Caremark Corporation Earnings Conference Call – Final OPERATOR: Good morning. My name is Cynthia and I will be your conference operator today. At this time, I would like to welcome everyone to the CVS/Caremark Corporation’s first quarter earnings conference call.All lines have been placed on mute to prevent any background noise. After the speaker’s remarks, there will be a question-and-answer session. (OPERATOR INSTRUCTIONS) I would now like to turn today’s call over to Nancy Christal, VP… . (USA) – –MEDICAL SUPPLIES, Amendment to Combined Synopsis/Solicitation NOTICE TYPE: Amendment to Combined Synopsis/Solicitation DATE POSTED: – - AGENCY: Department of Homeland Security OFFICE ADDRESS: Boswell Road, Chula Vista, CA SUBJECT: –Medical Supplies CLASSIFICATION CODE: – Medical, dental & veterinary equipment & supplies SOLICITATION NUMBER: CONTACT: Name: Teresita Bayquen, Title: purchasing agent, Phone: Fax: Email:… –